Vermathen and Vermalton Solutions are designed to replace blood plasma and electrolytes lost during haemodialysis sessions, offering several key benefits

Effective Treatment

These solutions help control phosphorus and parathormone levels, effectively limiting osseous disease associated with kidney dysfunction.

Safety Standards: Each solution is sterile, pyrogen-free, and aluminium-free, ensuring high safety standards are met for patient care.

Direct Action: Administered intravenously, these solutions work quickly and directly within the bloodstream, providing immediate effects.

Practical Design: Equipped with a double Luer/Lock connector for easy and direct access to bloodlines, and an injection port, enhancing convenience and reducing the potential for complications during use.

Reliability: Formulated to avoid precipitations, ensuring a smooth and effective infusion without clogging or interruption.

Regulatory Compliance: Pharmaceutical Products granted with Marketing Authorization Licenses issued by the Greek National Organization for Medicines (EOF). Adhere to the specifications of the current European Pharmacopoeia, guaranteeing high quality and consistency.

European Production: Manufactured in the European Union (Italy), these solutions meet rigorous production standards.

Types of Haemofiltration Solutions Offered

Vermathen

A lactate-based solution, tailored for patients needing specific electrolyte replacement.

Vermalton

A dual-chamber solution containing both bicarbonate and lactate, offering a balanced approach for comprehensive electrolyte replenishment.

These haemofiltration solutions are integral to managing the critical balance of electrolytes in patients undergoing haemodialysis, ensuring their safety and enhancing the effectiveness of the treatment process.